Skip to main content
. 2022 Nov 9;9:1028763. doi: 10.3389/fcvm.2022.1028763

TABLE 4.

Major adverse events within 30 days.

Group-n (%) Device-related complications Procedural complications
Pericardial effusion 6 (8.8) 1 (1.5)
Cardiac tamponade 0 (0.0) 0 (0.0)
Pleural effusion 0 (0.0) 0 (0.0)
Transient idioventricular rhythm 19 (27.9) 0 (0.0)
VT (> 120 bpm) 0 (0.0) 0 (0.0)
CLBBB 1 (1.5) 0 (0.0)
CRBBB 6 (8.8) 0 (0.0)
AVB 0 (0.0) 0 (0.0)
CHB 0 (0.0) 0 (0.0)
VF 1 (1.5) 0 (0.0)
Hypotension 1 (1.5) 0 (0.0)
Ventricular septal pseudoaneurysm 0 (0.0) 0 (0.0)
Ventricular septal perforation 0 (0.0) 0 (0.0)
Infection 0 (0.0) 0 (0.0)
Stroke 0 (0.0) 0 (0.0)
Recovery after SCD 1 (1.5) 0 (0.0)
Death 0 (0.0) 0 (0.0)

AVB, atrial ventricular block; CHB, complete heart block; CLBBB, complete left bundle branch block; CRBBB, complete right bundle branch block; SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia.